This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
bacteria:t3e:xopai [2023/12/11 10:17] – [Biological function] rkoebnik | bacteria:t3e:xopai [2025/02/12 23:26] (current) – jfpothier | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== XopAI ====== | + | ====== |
- | Author: [[https:// | + | Author: [[https:// |
- | Internal reviewer: \\ | + | |
- | Expert reviewer: **WANTED!** | + | |
Class: XopAI\\ | Class: XopAI\\ | ||
Line 18: | Line 16: | ||
Based on the complete genome sequence, XopAI (XAC3230) was proposed as a Hrp regulon candidate (da Silva //et al.//, 2002). | Based on the complete genome sequence, XopAI (XAC3230) was proposed as a Hrp regulon candidate (da Silva //et al.//, 2002). | ||
- | Co-regulation of //xopAI// with other HrpG-controlled genes was also proposed by Noël //et al.// (2006) based on the observation that 200 bp of the 5' sequence including promoter and coding regions of //xopE2// (// | + | Co-regulation of //xopAI// with other HrpG-controlled genes was also proposed by Noël //et al.// (2006) based on the observation that 200 bp of the 5' sequence including promoter and coding regions of //xopE2// (// |
Based on homology to effectors from // | Based on homology to effectors from // | ||
Line 27: | Line 25: | ||
=== Regulation === | === Regulation === | ||
- | Using microarrays, | + | Using microarrays, |
=== Phenotypes === | === Phenotypes === | ||
Line 41: | Line 39: | ||
XopAI was predicted to be a member of the arginine-specific mono-ADP-ribosyltransferase (mART) family. However, the crystal structure of XopAI revealed an altered active site that is unsuitable to bind the cofactor NAD+, but with the capability to capture an arginine-containing peptide from XopAI itself. Based on this finding, it was proposed that XopAI may not be a qualified mART, and it would exert different effects on host cells (Liu //et al.//, 2019). | XopAI was predicted to be a member of the arginine-specific mono-ADP-ribosyltransferase (mART) family. However, the crystal structure of XopAI revealed an altered active site that is unsuitable to bind the cofactor NAD+, but with the capability to capture an arginine-containing peptide from XopAI itself. Based on this finding, it was proposed that XopAI may not be a qualified mART, and it would exert different effects on host cells (Liu //et al.//, 2019). | ||
- | Structural homologs of XopAI are, among others, the HopU1 (// | + | Structural homologs of XopAI are, among others, the HopU1 (// |
=== Interaction partners === | === Interaction partners === | ||
Line 48: | Line 46: | ||
=== In xanthomonads === | === In xanthomonads === | ||
- | XopAI is conserved in the Citrus canker strains, including //X. citri// pv. //citri// and //X. citri// pv. // | + | XopAI is conserved in the Citrus canker strains, including //X. citri// pv. //citri// and //X. citri// pv. // |
- | XopAI homologs were also found in //X. citri// pv. //bilvae// and //X. citri// pv. // | + | XopAI homologs were also found in //X. citri// pv. //bilvae// and //X. citri// pv. // |
=== In other plant pathogens/ | === In other plant pathogens/ | ||